Citation, commencement, interpretation and extent

1.–(1) This Order may be cited as the Misuse of Drugs (Designation) (Amendment No.2) (England, Wales and Scotland) Order 2010 and shall come into force on 23rd July 2010.

(2) In this Order "the 2001 Order" means the Misuse of Drugs (Designation) Order 2001(2).

(3) This Order extends to England, Wales and Scotland.

Amendment to the 2001 Order

2. In Part 1 of the Schedule to the 2001 Order after paragraph 1(q), insert–

"(r) Any compound structurally derived from 2-aminopropan-1-one by substitution at the 1-‘position with any monocyclic, or fused-‘polycyclic ring system (not being a phenyl ring or alkylenedioxyphenyl ring system), whether or not the compound is further modified in any of the following ways, that is to say,

(i) by substitution in the ring system to any extent with alkyl, alkoxy, haloalkyl or halide substituents, whether or not further substituted in the ring system by one or more other univalent substituents;

(ii) by substitution at the 3-position with an alkyl substituent;

(iii) by substitution at the 2-‘amino nitrogen atom with alkyl or dialkyl groups, or by inclusion of the 2-‘amino nitrogen atom in a cyclic structure.".

EXPLANATORY NOTE

(This note is not part of the Order)

Section 7(3) of the Misuse of Drugs Act 1971 requires regulations to be made to allow the use for medical purposes of the drugs which are subject to control under that Act. Section 7(3) does not apply to any drug designated by order under section 7(4) as a drug to which section 7(4) is to apply. This Order amends the Misuse of Drugs (Designation) Order 2001 by inserting into Part 1 of the Schedule to that Order a further group of cathinone derivatives (including naphthylpyrovalerone, commonly known as naphyrone).